Dashboard Tools Market News Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

USANA Health Sciences Inc
XMUN:USJ

Watchlist Manager
USANA Health Sciences Inc Logo
USANA Health Sciences Inc
XMUN:USJ
Watchlist
Price: 12.9 EUR Market Closed
Market Cap: €478.3m
Write Note Create Alert Ask AI

Wall St Price Targets

USJ Price Targets Summary
USANA Health Sciences Inc

Wall Street analysts forecast USJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for USJ is 22.18 EUR with a low forecast of 21.96 EUR and a high forecast of 22.83 EUR.

USJ Lowest Forecast
Wall Street Target
€21.96
70% Upside
USJ Average Forecast
Wall Street Target
€22.18
72% Upside
USJ Highest Forecast
Wall Street Target
€22.83
77% Upside
Lowest Forecast
Price Target
21.96 EUR
70% Upside
Average Forecast
Price Target
22.18 EUR
72% Upside
Highest Forecast
Price Target
22.83 EUR
77% Upside
USANA Health Sciences Inc Competitors:
Price Targets

Revenue
Forecast

3% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
3% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is 2%.

What are analyst estimates?

Gross Profit
Forecast

2% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
2% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 2 years is 2%.

What are analyst estimates?

Operating Income
Forecast

-5% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
-5% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 2 years is 18%.

What are analyst estimates?

Pre-Tax Income
Forecast

-6% / Year
Past Growth
104% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
-6% / Year
Past Growth
104% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -6%. The projected CAGR for the next 1 year is 104%.

What are analyst estimates?

Net Income
Forecast

-13% / Year
Past Growth
120% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-13% / Year
Past Growth
120% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been -13%. The projected CAGR for the next 2 years is 120%.

What are analyst estimates?

Continue USJ Research

Summary
USJ intrinsic value, competitors valuation, and company profile.
DCF Valuation
USJ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
USJ stock valuation using valuation multiples.
Wall St Estimates
USJ price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
USJ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other USANA Health Sciences Inc listings:
NYSE • USD
USNA
 F • EUR
USJ
 SWB • EUR
USJ
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is USJ's stock price target?
Price Target
22.18 EUR

According to Wall Street analysts, the average 1-year price target for USJ is 22.18 EUR with a low forecast of 21.96 EUR and a high forecast of 22.83 EUR.

What is the Revenue forecast for USANA Health Sciences Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is 2%.

What is the Gross Profit forecast for USANA Health Sciences Inc?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 2 years is 2%.

What is the Operating Income forecast for USANA Health Sciences Inc?
Projected CAGR
18%

Over the last 13 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 2 years is 18%.

What is the Pre-Tax Income forecast for USANA Health Sciences Inc?
Projected CAGR
104%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -6%. The projected CAGR for the next 1 year is 104%.

What is the Net Income forecast for USANA Health Sciences Inc?
Projected CAGR
120%

Over the last 13 years, the compound annual growth rate for Net Income has been -13%. The projected CAGR for the next 2 years is 120%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett